DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Is Prevest Denpro Ltd or CIPLA LTD a better stock to buy?

Prevest Denpro Ltd (543363), CIPLA LTD (CIPLA) are compared on DocStoX across valuation, profitability, growth and financial health. On P/E: Prevest Denpro Ltd at 22.7, CIPLA LTD at 28.9. On ROE: Prevest Denpro Ltd at 18.5%, CIPLA LTD at 11.6%. The better pick depends on whether you prioritise valuation, growth or balance-sheet strength.

Prevest Denpro Ltd vs CIPLA LTD: which has the lowest PE ratio?

Prevest Denpro Ltd has the lowest PE ratio — Prevest Denpro Ltd is at 22.7, CIPLA LTD is at 28.9. A lower PE can signal a cheaper valuation, though it must be read alongside growth and quality.

Which is bigger, Prevest Denpro Ltd or CIPLA LTD?

CIPLA LTD is the largest by market capitalisation — Prevest Denpro Ltd is ₹468 crore, CIPLA LTD is ₹1,12,634 crore.

Prevest Denpro Ltd vs CIPLA LTD

A side-by-side comparison of Prevest Denpro Ltd (543363) and CIPLA LTD (CIPLA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

Prevest Denpro Ltd vs CIPLA LTD are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

Valuation13
Profitability40
Growth11
Size & financial health13

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

CIPLA takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

22.70

P/E ratio

28.90

3.72

P/B ratio

3.42

0.26%

Dividend yield

0.95%

₹15.16

EPS

₹48.02

Profitability

543363 takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

18.50%

Return on equity

11.60%

25.00%

Return on capital

15.00%

35.00%

EBITDA margin

21.00%

28.57%

Net margin

13.71%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

12.82%

Revenue CAGR (3Y)

7.37%

9.03%

Profit CAGR (3Y)

10.88%

Size & financial health

CIPLA takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹468 Cr

Market cap

₹1.13L Cr

₹63 Cr

Revenue

₹28,163 Cr

₹18 Cr

Net profit

₹3,862 Cr

0.00

Debt / equity

0.00

Prevest Denpro Ltd

+ ["Company is almost debt free."]

CIPLA LTD

+ ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]

− ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.24%"]

Prevest Denpro Ltd full analysis CIPLA LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.